Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R McKay

Showing results (741-750 of 932) with videos related to

Pageof 94
Sort By:
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|December 17, 2023
Molecular Characterization of TFE3-Rearranged Renal Cell Carcinoma: A Comparative Study With Papillary and Clear Cell Renal Cell CarcinomasShuanzeng Wei, Harris B Krause, Daniel M Geynisman, et al.
Clinical Genitourinary Cancer|January 19, 2016
Duration of Androgen Deprivation Therapy for High-Risk Prostate Cancer: Application of Randomized Trial Data in a Tertiary Referral Cancer CenterVinayak Muralidhar, Meredith M Regan, Lillian Werner, et al.
Prostate Cancer and Prostatic Diseases|December 22, 2017
Post prostatectomy outcomes of patients with high-risk prostate cancer treated with neoadjuvant androgen blockadeRana R McKay, Bruce Montgomery, Wanling Xie, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 8, 2026
Investigation of Profile-Related Evidence Determining Individualized Cancer Therapy (I-PREDICT) N-of-1 Precision Oncology Study: Molecular Profiling to Match Individually Dosed, Personalized Drug CombinationsJason K Sicklick, Daisuke Nishizaki, Hirotaka Miyashita, et al.
Drug and Alcohol Dependence|April 27, 2025
The continuing care project: A multi-arm randomised controlled trial of a continuing care telephone intervention following residential substance use treatmentPeter J Kelly, Frank P Deane, Amanda L Baker, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 30, 2022
Enfortumab Vedotin Plus Pembrolizumab in Previously Untreated Advanced Urothelial CancerChristopher J Hoimes, Thomas W Flaig, Matthew I Milowsky, et al.
Cancer Medicine|April 21, 2025
Metabolic Syndrome Among Testicular Cancer Survivors: Long-Term Follow-Up of the Veterans Affairs Health SystemDhruv Puri, Paul Riviere, Margaret Meagher, et al.
Scientific Reports|July 4, 2015
In vivo bioimaging with tissue-specific transcription factor activated luciferase reportersSuzanne M K Buckley, Juliette M K M Delhove, Dany P Perocheau, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 6, 2016
A Randomized Phase II Trial of Short-Course Androgen Deprivation Therapy With or Without Bevacizumab for Patients With Recurrent Prostate Cancer After Definitive Local TherapyRana R McKay, Amado J Zurita, Lillian Werner, et al.
Clinical Genitourinary Cancer|January 14, 2020
Clinical Outcomes of First-line Sunitinib Followed by Immuno-oncology Checkpoint Inhibitors in Patients With Metastatic Renal Cell CarcinomaJ Connor Wells, Jeffrey Graham, Benoit Beuselinck, et al.
Pageof 94

Showing results (741-750 of 932) with videos related to

Sort By:
Pageof 94
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|December 17, 2023
Molecular Characterization of TFE3-Rearranged Renal Cell Carcinoma: A Comparative Study With Papillary and Clear Cell Renal Cell CarcinomasShuanzeng Wei, Harris B Krause, Daniel M Geynisman, et al.
Clinical Genitourinary Cancer|January 19, 2016
Duration of Androgen Deprivation Therapy for High-Risk Prostate Cancer: Application of Randomized Trial Data in a Tertiary Referral Cancer CenterVinayak Muralidhar, Meredith M Regan, Lillian Werner, et al.
Prostate Cancer and Prostatic Diseases|December 22, 2017
Post prostatectomy outcomes of patients with high-risk prostate cancer treated with neoadjuvant androgen blockadeRana R McKay, Bruce Montgomery, Wanling Xie, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 8, 2026
Investigation of Profile-Related Evidence Determining Individualized Cancer Therapy (I-PREDICT) N-of-1 Precision Oncology Study: Molecular Profiling to Match Individually Dosed, Personalized Drug CombinationsJason K Sicklick, Daisuke Nishizaki, Hirotaka Miyashita, et al.
Drug and Alcohol Dependence|April 27, 2025
The continuing care project: A multi-arm randomised controlled trial of a continuing care telephone intervention following residential substance use treatmentPeter J Kelly, Frank P Deane, Amanda L Baker, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 30, 2022
Enfortumab Vedotin Plus Pembrolizumab in Previously Untreated Advanced Urothelial CancerChristopher J Hoimes, Thomas W Flaig, Matthew I Milowsky, et al.
Cancer Medicine|April 21, 2025
Metabolic Syndrome Among Testicular Cancer Survivors: Long-Term Follow-Up of the Veterans Affairs Health SystemDhruv Puri, Paul Riviere, Margaret Meagher, et al.
Scientific Reports|July 4, 2015
In vivo bioimaging with tissue-specific transcription factor activated luciferase reportersSuzanne M K Buckley, Juliette M K M Delhove, Dany P Perocheau, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 6, 2016
A Randomized Phase II Trial of Short-Course Androgen Deprivation Therapy With or Without Bevacizumab for Patients With Recurrent Prostate Cancer After Definitive Local TherapyRana R McKay, Amado J Zurita, Lillian Werner, et al.
Clinical Genitourinary Cancer|January 14, 2020
Clinical Outcomes of First-line Sunitinib Followed by Immuno-oncology Checkpoint Inhibitors in Patients With Metastatic Renal Cell CarcinomaJ Connor Wells, Jeffrey Graham, Benoit Beuselinck, et al.
Pageof 94